Showing results (61-70 of 84) with videos related to
Sort By:
Pageof 9
Gastroenterology|November 22, 2017
Combination of Gene Expression Signature and Model for End-Stage Liver Disease Score Predicts Survival of Patients With Severe Alcoholic HepatitisEric Trépo, Nicolas Goossens, Naoto Fujiwara, et al.Gastroenterology|January 11, 2018
Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn's DiseaseGeert D'Haens, Severine Vermeire, Guy Lambrecht, et al.The Lancet. Gastroenterology & Hepatology|July 30, 2018
Risankizumab in patients with moderate to severe Crohn's disease: an open-label extension studyBrian G Feagan, Julián Panés, Marc Ferrante, et al.The Journal of Experimental Medicine|May 15, 2013
CD47 fusion protein targets CD172a+ cells in Crohn's disease and dampens the production of IL-1β and TNFNobuyasu Baba, Vu Quang Van, Keiko Wakahara, et al.Inflammatory Bowel Diseases|April 12, 2007
Assessment of reliability and validity of IBD phenotyping within the National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK) IBD Genetics Consortium (IBDGC)Themistocles Dassopoulos, Geoffrey C Nguyen, Alain Bitton, et al.Nature Genetics|December 15, 2010
Resequencing of positional candidates identifies low frequency IL23R coding variants protecting against inflammatory bowel diseaseYukihide Momozawa, Myriam Mni, Kayo Nakamura, et al.Journal of Crohn'S & Colitis|March 29, 2023
Prevalence and Determinants of Fatigue in Patients with IBD: A Cross-Sectional Survey from the GETAIDAurelien Amiot, Sayma Chaibi, Yoram Bouhnik, et al.Journal of Crohn'S & Colitis|November 27, 2020
The IBD-disk Is a Reliable Tool to Assess the Daily-life Burden of Patients with Inflammatory Bowel DiseaseSara Tadbiri, Maria Nachury, Yoram Bouhnik, et al.Gastroenterology|March 5, 2018
Analysis of Genes Associated With Monogenic Primary Immunodeficiency Identifies Rare Variants in XIAP in Patients With Crohn's DiseaseLeila Amininejad, Benoit Charloteaux, Emilie Theatre, et al.Lancet (London, England)|October 16, 2012
Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trialDavid Laharie, Arnaud Bourreille, Julien Branche, et al.Pageof 9